Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
10.30
+0.71 (7.40%)
Oct 19, 2026, 1:18 PM EDT - Market open
RGC Market Cap
RGC has a market cap or net worth of $5.11 billion as of October 19, 2026. It is the 3,723rd most valuable company in the world and the 1,176th biggest in the United States. Its market cap has decreased by 40.67% in one year.
Market Cap
5.11B
Enterprise Value
5.09B
1-Year Change
-40.67%
Global Rank
Country Rank
#1,176 United States
Category
ChartMarket Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $5.11B, an increase of 4,152.80%. That is a compound annual growth rate of 103.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 5.11B | -50.81% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 6.92B |
| Amneal Pharmaceuticals | 6.68B |
| Hims & Hers Health | 6.55B |
| Lantheus Holdings | 6.51B |
| Kiniksa Pharmaceuticals International, | 6.13B |
| Indivior Pharmaceuticals | 3.83B |
| Amylyx Pharmaceuticals | 3.31B |
| Liquidia | 3.07B |